Pegasus Partners Ltd. Pfizer Inc Transaction History

Pegasus Partners Ltd.

$1.07 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $156,753 - $203,606	-5,999 Reduced 11.38%	46,700 $1.34 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $15,018 - $17,554	468 Added 0.9%	52,699 $1.75 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $80,439 - $93,066	-2,227 Reduced 4.09%	52,231 $1.92 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $356,400 - $463,981	9,048 Added 19.93%	54,458 $2.22 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $165,371 - $215,874	-3,961 Reduced 8.02%	45,410 $2.33 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $49,054 - $59,883	-1,121 Reduced 2.22%	49,371 $2.16 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $50,066 - $59,362	1,076 Added 2.18%	50,492 $2.65 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $51,468 - $63,776	1,125 Added 2.33%	49,416 $2.56 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $586,206 - $868,953	-14,187 Reduced 22.71%	48,291 $2.85 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $188,478 - $242,116	-4,802 Reduced 7.14%	62,478 $2.69 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $549,099 - $622,037	-15,291 Reduced 18.52%	67,280 $2.64 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $965,081 - $1.09 Million	-28,817 Reduced 25.87%	82,571 $2.99 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $34,105 - $43,368	1,019 Added 0.92%	111,388 $4.1 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $262,286 - $307,722	8,261 Added 8.09%	110,369 $4.05 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $180,418 - $218,874	5,990 Added 6.23%	102,108 $3.34 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $688,589 - $983,844	25,475 Added 36.06%	96,118 $3.14 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $795,083 - $902,318	24,152 Added 51.95%	70,643 $2.77 Million
Q3 2019 Oct 24, 2019	BUY	$32.49 - $42.13 $984,024 - $1.28 Million	30,287 Added 186.91%	46,491 $1.67 Million
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $90,490 - $101,599	-2,447 Reduced 13.12%	16,204 $702,000
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $100,725 - $110,663	2,686 Added 16.82%	18,651 $792,000
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $25,197 - $30,563	-731 Reduced 4.38%	15,965 $704,000
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $13,422 - $14,310	-407 Reduced 2.38%	16,696 $606,000
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $1.12 Million - $1.3 Million	-35,077 Reduced 67.22%	17,103 $607,000
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $680,699 - $722,245	-20,466 Reduced 28.17%	52,180 $1.89 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $2.25 Million - $2.48 Million	72,646	72,646 $2.59 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.

Account